Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid

Case 1: A 65-year-old man with novel coronavirus infection (COVID-19) complicated with acute respiratory failure. On admission, the patient was started on favipiravir and corticosteroid. However, due to a lack of significant improvement, he was introduced to mechanical ventilation and extracorporeal...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinoda, Masahiro, Kamachi, Kenichi, Ota, Shinichiro, Yoshimatsu, Lynn, Boku, Ryuichi, Yoshida, Yuto, Hirouchi, Takatomo, Shinada, Kanako, Sato, Takashi, Morikawa, Miwa, Iwata, Koki, Matsumoto, Takashi, Shinkai, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835466/
https://www.ncbi.nlm.nih.gov/pubmed/33390469
http://dx.doi.org/10.2169/internalmedicine.5475-20
_version_ 1783642533876727808
author Shinoda, Masahiro
Kamachi, Kenichi
Ota, Shinichiro
Yoshimatsu, Lynn
Boku, Ryuichi
Yoshida, Yuto
Hirouchi, Takatomo
Shinada, Kanako
Sato, Takashi
Morikawa, Miwa
Iwata, Koki
Matsumoto, Takashi
Shinkai, Masaharu
author_facet Shinoda, Masahiro
Kamachi, Kenichi
Ota, Shinichiro
Yoshimatsu, Lynn
Boku, Ryuichi
Yoshida, Yuto
Hirouchi, Takatomo
Shinada, Kanako
Sato, Takashi
Morikawa, Miwa
Iwata, Koki
Matsumoto, Takashi
Shinkai, Masaharu
author_sort Shinoda, Masahiro
collection PubMed
description Case 1: A 65-year-old man with novel coronavirus infection (COVID-19) complicated with acute respiratory failure. On admission, the patient was started on favipiravir and corticosteroid. However, due to a lack of significant improvement, he was introduced to mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Although iliopsoas hematoma occurred as a complication, the patient recovered. Case 2: A 49-year-old man with COVID-19 had been started on favipiravir and corticosteroid. Due to progressive respiratory failure, the patient underwent mechanical ventilation and ECMO. The patient recovered without complications. We successfully treated these severe cases with a multimodal combination of pharmacological and non-pharmacological supportive therapy.
format Online
Article
Text
id pubmed-7835466
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-78354662021-02-04 Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid Shinoda, Masahiro Kamachi, Kenichi Ota, Shinichiro Yoshimatsu, Lynn Boku, Ryuichi Yoshida, Yuto Hirouchi, Takatomo Shinada, Kanako Sato, Takashi Morikawa, Miwa Iwata, Koki Matsumoto, Takashi Shinkai, Masaharu Intern Med Case Report Case 1: A 65-year-old man with novel coronavirus infection (COVID-19) complicated with acute respiratory failure. On admission, the patient was started on favipiravir and corticosteroid. However, due to a lack of significant improvement, he was introduced to mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Although iliopsoas hematoma occurred as a complication, the patient recovered. Case 2: A 49-year-old man with COVID-19 had been started on favipiravir and corticosteroid. Due to progressive respiratory failure, the patient underwent mechanical ventilation and ECMO. The patient recovered without complications. We successfully treated these severe cases with a multimodal combination of pharmacological and non-pharmacological supportive therapy. The Japanese Society of Internal Medicine 2021-01-01 2021-01-01 /pmc/articles/PMC7835466/ /pubmed/33390469 http://dx.doi.org/10.2169/internalmedicine.5475-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Shinoda, Masahiro
Kamachi, Kenichi
Ota, Shinichiro
Yoshimatsu, Lynn
Boku, Ryuichi
Yoshida, Yuto
Hirouchi, Takatomo
Shinada, Kanako
Sato, Takashi
Morikawa, Miwa
Iwata, Koki
Matsumoto, Takashi
Shinkai, Masaharu
Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid
title Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid
title_full Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid
title_fullStr Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid
title_full_unstemmed Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid
title_short Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid
title_sort two cases of severe covid-19 pneumonia effectively treated with extracorporeal membrane oxygenation in addition to favipiravir and corticosteroid
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835466/
https://www.ncbi.nlm.nih.gov/pubmed/33390469
http://dx.doi.org/10.2169/internalmedicine.5475-20
work_keys_str_mv AT shinodamasahiro twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT kamachikenichi twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT otashinichiro twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT yoshimatsulynn twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT bokuryuichi twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT yoshidayuto twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT hirouchitakatomo twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT shinadakanako twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT satotakashi twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT morikawamiwa twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT iwatakoki twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT matsumototakashi twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid
AT shinkaimasaharu twocasesofseverecovid19pneumoniaeffectivelytreatedwithextracorporealmembraneoxygenationinadditiontofavipiravirandcorticosteroid

Ejemplares similares